Dundee has made a significant breakthrough in the fight against tuberculosis
- Andrew Batchelor
- 2 days ago
- 1 min read
Researchers at the University of Dundee have taken an important step forward in the global fight against tuberculosis (TB) after identifying a promising new drug candidate that could lead to future treatments.
The university has revealed a new pre-clinical compound known as DDU384, developed through a collaboration between its scientists and pharmaceutical company GSK.
The discovery could help pave the way for new therapies aimed at tackling one of the world’s deadliest infectious diseases.
Tuberculosis remains a major global health challenge, claiming around 1.2 million lives every year.
Despite decades of medical progress, the disease continues to affect millions of people worldwide, making the search for more effective treatments a priority for researchers.
The newly identified compound will now move forward into further testing to understand how well it can combat the disease.
These trials will help scientists determine whether it could eventually be developed into a medicine capable of treating TB.
The breakthrough highlights the ongoing role Dundee plays in global medical research. The city has long been recognised for its work in life sciences, with research carried out at the University of Dundee and Ninewells Hospital contributing to major advances in medicine.
While the drug candidate is still in its early stages, researchers hope it could eventually become part of the next generation of treatments for tuberculosis. If successful, the work being carried out in Dundee could help save lives around the world.
